DEK gene present in plasma can help predict outcomes for patients with head and neck

[News]

Researchers at the University of Cincinnati have discovered that a human cancer-causing gene, called DEK, can be detected in the plasma of head and neck cancer patients. DEK may help doctors understand how a person's immune system could be used to treat cancer or predict outcomes for patients.

More... (http://www.news-medical.net/news/20160218/DEK-gene-present-in-plasma-can-help-predict-outcomes-for-patients-with-head-and-neck-cancer.aspx)